Verdine Gregory L. 4
4 · Wave Life Sciences Ltd. · Filed Oct 28, 2022
Insider Transaction Report
Form 4
Verdine Gregory L.
Director
Transactions
- Award
Share Option (right to buy)
2022-10-27+163,467→ 163,467 totalExercise: $4.37Exp: 2027-10-27→ Ordinary Shares (163,467 underlying)
Footnotes (1)
- [F1]The reporting person was granted this option pursuant to his existing consulting agreement with Wave. The option vests in equal monthly installments beginning on October 31, 2022, through December 31, 2024, subject to the reporting person's continued services through the applicable vesting date.